Drugs with this side effect
- 18F-FDG
- 2-hydroxysuccinaldehyde: 1% - 3%
- 4-PBA: common
- 5-ASA: postmarketing
- 5-FU
- 5-aminolevulinic acid: 0% - 1%
- 5-aza-2'-deoxycytidine: 5.05% - 18.1%
- 6-mercaptopurine
- 8-MOP
- BCNU
- CAS 76095-16-4
- CGP 19835A: common
- Cancidas: 0% - 8%
- EACA
- Estrofem
- FAMP
- Fe(III: postmarketing
- Forteo: rare
- Gd-EOB-DTPA
- Ge-132: 12%
- Glat copolymer
- Goserelin: 0% - 8%
- Humalog
- Implanon: postmarketing
- Insulin
- K779
- L-Dmp: infrequent
- LMWH: 1% - 2%
- LY146032: 4.3% - 6.7%
- Lantus
- Leuprorelin
- LiOH
- Lisinopril: 0.6% - 2.5%
- Lovaza
- MK-462: postmarketing
- Madopar
- Meropenem anhydrous
- Metrodin
- N-acetylcysteine: 1.2% - 1.6%
- Nafarelin
- NovoLog: uncommon
- NuvaRing
- Octreotide: 1-3%
- Oestrogen: uncommon
- Optison: postmarketing
- PGE1: 1.1%
- Photofrin: 16% - 18%
- Photofrin II
- Refludan
- Revasc
- Romidepsin: 5%
- Stalevo 50
- Supremon: 2.98%
- Triptorelin: 6.3%
- UDCA
- VACV: 4% - 54%
- abacavir
- abacavir-lamivudine
- abiraterone: 0.4% - 1.9%
- acarbose: postmarketing
- acebutolol: 1% - 4%
- acetaminophen: postmarketing
- acitretin: postmarketing, 1-10%
- actinomycin D
- acyclovir
- alfuzosin: postmarketing, uncommon
- aliskiren
- allopurinol
- alprazolam: infrequent, 4.9% - 5.6%
- amantadine: postmarketing
- ambrisentan
- amiodarone: postmarketing
- amitriptyline
- amlodipine: 1.4% - 14.6%
- amlodipine besylate: 1.4% - 14.6%
- amoxapine
- amphotericin B: 14.3% - 14.8%
- anagrelide
- anastrozole: 7% - 14%
- anthracycline: 1% - 9%
- apomorphine: 10%
- apraclonidine
- aprepitant
- aripiprazole
- arsenic
- arsenic trioxide
- articaine
- atazanavir: postmarketing, rare
- atenolol
- atropine: rare
- azelaic acid: 0% - 1%
- azithromycin: postmarketing
- baclofen
- benazepril
- benazeprilat
- benzathine penicillin
- benzocaine
- benzoyl
- benzyl alcohol
- bepridil
- betaxolol: 0% - 1.8%
- bexarotene: 0% - 10%
- bicalutamide
- bisoprolol: 3% - 3.7%
- bleomycin hydrochloride
- bortezomib: 0% - 28.4%
- bosentan: 28%
- bosutinib
- brimonidine: common
- bromocriptine
- bupivacaine
- buprenorphine
- bupropion: postmarketing, infrequent, frequent
- buspirone: infrequent
- busulfan: 28% - 79%
- butorphanol: infrequent
- cabazitaxel
- cabergoline: postmarketing
- calcium: postmarketing
- capecitabine: 1% - 34%
- carbamazepine: common
- carbidopa
- carteolol
- carvedilol: 0.2% - 5.1%
- cefaclor: postmarketing
- ceftriaxone: postmarketing
- celecoxib
- cerivastatin
- cetirizine: postmarketing
- cevimeline
- chlordiazepoxide
- cidofovir
- cilazapril
- cilostazol
- cinoxacin
- ciprofloxacin: postmarketing, rare, uncommon
- cisplatin
- citalopram: postmarketing, rare, infrequent, uncommon
- cladribine: common, 6%
- clindamycin phosphate
- clobetasol
- clofarabine: common
- clofazimine
- clomiphene citrate: postmarketing
- clomipramine: very rare, infrequent
- clonazepam
- clonidine
- clopidogrel
- clotrimazole
- clozapine
- colestyramine
- conjugated estrogens: postmarketing
- copolymer 1
- cortisol
- crizotinib: 0% - 39%
- cyclobenzaprine: postmarketing
- cyclophosphamide: postmarketing
- cyproheptadine
- cyproterone: 2%
- cyproterone acetate
- cytarabine: 2.33% - 21.4%
- cytokinin
- dabrafenib
- danazol: 6%
- darifenacin: uncommon
- dasatinib: 0% - 36%
- deferasirox: uncommon
- deferoxamine: uncommon
- delavirdine
- deprenyl: infrequent
- desipramine
- desloratadine: postmarketing
- desmopressin
- dexamethasone
- diatrizoate
- diazoxide
- diclofenac: postmarketing, rare, 0% - 33%
- dicyclomine: postmarketing
- diflunisal
- dihydroergotamine: infrequent
- diltiazem: 1.9% - 14.6%
- dipyridamole: 0.03%
- disopyramide
- docetaxel: 0% - 27%
- dofetilide
- dolasetron
- domperidone
- donepezil: frequent
- dorzolamide
- doxazosin: 1% - 6.6%
- doxepin: 0.299% - 1.21%
- doxercalciferol: 34.4%
- doxorubicin: uncommon, common
- duloxetine: infrequent
- eletriptan: infrequent
- erlotinib
- ertapenem: 2.9% - 3.4%
- eslicarbazepine acetate
- esmolol
- estazolam: rare
- estradiol: postmarketing, common, 0.5% - 13%
- estradiol cypionate
- estradiol valerate
- estramustine: 17% - 19%
- estramustine phosphate
- estrone
- etodolac
- etoricoxib
- everolimus: 0.5% - 39%
- exemestane: 2-5% - 7%
- famotidine
- febuxostat
- felbamate
- fenofibrate
- fentanyl: postmarketing
- ferumoxytol: 1.4% - 1.5%
- flecainide: 1.4% - 3.5%
- fludarabine: 8% - 19%
- fludrocortisone
- flunisolide
- fluocinolone acetonide
- fluorescein: postmarketing
- flurbiprofen
- flutamide
- fluticasone: postmarketing
- fluticasone propionate: very rare
- fluvoxamine: rare, frequent
- fondaparinux: uncommon, 8.66% - 8.8%
- formoterol
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fosinopril: uncommon
- fosinoprilat
- gabapentin: infrequent
- gadolinium: postmarketing
- gadoteridol
- gadoversetamide
- ganciclovir: 9%
- gatifloxacin: 0.5%
- gemcitabine: very rare, very common, 13%
- gemfibrozil
- gemifloxacin: postmarketing
- glibenclamide
- glipizide
- glucose
- glutamine: 0% - 81.2%
- glycine
- glycopyrrolate
- granisetron
- guanfacine: postmarketing
- halcinonide
- haloperidol: very rare, postmarketing
- heparin
- homatropine
- hydralazine: uncommon
- hydrochlorothiazide: 1.3%
- hydroxybutyrate
- hydroxychloroquine
- hydroxyl radicals
- hydroxypropyl
- hydroxyurea
- ibuprofen: 4%
- icodextrin: postmarketing, 5% - 6%
- ifosfamide: postmarketing
- iloperidone
- imatinib: very common, 0% - 86.1%
- imipramine: very rare
- imiquimod: 0% - 78%
- indapamide: 2%
- indinavir
- indomethacin
- insulin detemir
- iodixanol
- iopromide: postmarketing
- ioxaglate
- ioxilan
- ipratropium bromide: postmarketing
- irbesartan
- irbesartan-hydrochlorothiazide
- irinotecan: 1% - 10%
- iron sucrose: 16.5%
- isomannide
- isosorbide-5-mononitrate
- isradipine: 2.9% - 7.2%
- itraconazole: 1% - 4%
- ivermectin
- ixabepilone: 0% - 9%
- ketoprofen
- ketorolac: 4%
- ketorolac tromethamine: postmarketing, 4%
- labetalol: 0% - 1%
- lamivudine
- lamotrigine: rare, 2%
- lanreotide
- lansoprazole: postmarketing
- lasofoxifene: rare
- latanoprost
- lenalidomide: postmarketing, common
- letrozole: uncommon, 0.0251% - 18.4%
- leuprorelin acetate: 8% - 23%
- levodopa/carbidopa
- levonorgestrel
- lidocaine
- liraglutide: postmarketing
- lithium
- lithium carbonate
- lodoxamide
- lodoxamide tromethamine
- lomefloxacin
- losartan: 1.7%
- loxapine
- lubiprostone: 3%
- mTHPC: common
- macitentan
- mannitol
- maprotiline
- maraviroc
- meclofenamate: postmarketing
- medroxyprogesterone: 2.2%
- medroxyprogesterone acetate
- mefenamic acid
- mefloquine: postmarketing
- megestrol
- megestrol acetate
- meloxicam: 0.6% - 4.5%
- melphalan: rare
- memantine
- meperidine
- mephenytoin
- mepivacaine
- meropenem
- mesna: 6.7% - 9%
- metaproterenol: 0.2% - 1%
- methadone
- methimazole
- methyl aminolevulinate: postmarketing, 1.64% - 15.4%
- methyldopa
- methylnaltrexone
- methylphenidate: postmarketing
- methysergide
- metipranolol
- metoclopramide
- metoprolol: rare, uncommon
- metronidazole
- mexiletine: 3.8%
- mianserin
- mifepristone
- minoxidil
- mirtazapine: postmarketing, 1% - 1.32%
- misoprostol: postmarketing
- mitomycin C
- mitoxantrone: 10-31%
- modafinil: postmarketing
- montelukast: postmarketing
- morphine
- moxifloxacin: uncommon
- mycophenolate mofetil: 11.8% - 28.2%
- mycophenolic acid: 16.9% - 28.2%
- nabumetone: 0.7%
- nadolol
- nalbuphine
- naltrexone
- nandrolone
- nandrolone decanoate
- naproxen: postmarketing
- naratriptan: infrequent
- nefazodone
- nelarabine: 0% - 15%
- nelfinavir: postmarketing
- nevirapine: postmarketing
- niacin
- nicardipine: 0.192%
- nicorandil: uncommon
- nicotine: 1.9%
- nifedipine: postmarketing, 9.9% - 10.1%
- nilotinib
- nilutamide: 2%
- nimodipine: 0%
- nisoldipine
- nitazoxanide
- norethisterone
- norfloxacin
- nortriptyline
- ofloxacin
- ogen
- olanzapine: 2%
- olmesartan
- olopatadine
- orlistat: uncommon
- oxaliplatin: 1% - 13%
- oxandrolone
- oxaprozin
- oxazepam
- oxybutynin: 1%
- oxycodone
- oxymetholone
- oxymorphone
- paclitaxel: postmarketing, rare, very common, 10%
- paliperidone: uncommon
- pamidronate: very rare, uncommon, 0% - 1%
- pantoprazole
- paricalcitol: 5.6% - 6.5%
- paroxetine: postmarketing, infrequent, uncommon
- pazopanib
- pemetrexed: postmarketing, 0% - 24%
- penicillin
- pentosan polysulfate
- pentoxifylline
- pergolide: 1.6%
- perindopril: 3.9%
- perindopril erbumine: 3.9% - 4.3%
- phenelzine
- phentermine
- phenylbutyric acid
- pilocarpine: 5%
- pimecrolimus
- pindolol: 1% - 6%
- pioglitazone: postmarketing, 0% - 26.7%
- piperacillin
- pirbuterol
- piroxicam: 2.7%
- pixantrone
- pizotifen
- podophyllotoxin
- ponatinib: 0% - 22%
- posaconazole
- pralatrexate
- pramipexole: 4% - 5%
- pravastatin: 0.6% - 3%
- prazosin: 4%
- prednicarbate
- prednisolone
- prednisolone acetate
- prednisone
- pregabalin: 0% - 8.2%
- prilocaine
- procaine
- procaine penicillin
- procarbazine
- prochlorperazine
- progesterone
- promethazine
- propafenone: 0.2% - 7.35%
- propericiazine
- propofol
- propylthiouracil
- prostacyclin
- protriptyline
- quinapril
- quinaprilat
- quinidine
- rabeprazole
- radium
- raltitrexed: 3-5%
- ramipril: 0.2%
- ramiprilat
- rapamycin: 15% - 24%
- remifentanil: 0% - 3.41%
- repaglinide
- rescinnamine
- reserpine
- retinoic acid: postmarketing, common, 0% - 29%
- ribavirin: common
- rifampicin
- riluzole: infrequent
- rimexolone
- risperidone: postmarketing, infrequent, 1% - 1.15%
- ritonavir
- rivaroxaban
- rivastigmine: infrequent, common, frequent
- rizatriptan: rare
- ropinirole: infrequent
- rosiglitazone
- salbutamol: postmarketing, 0% - 2.8%
- salicylate
- salmeterol: very rare
- salmon calcitonin acetate: postmarketing, uncommon
- saquinavir
- scopolamine
- sertraline: infrequent
- sevoflurane: postmarketing
- sibutramine
- sildenafil: postmarketing, 13% - 14%
- simvastatin: 2.7%
- sitaxsentan: common
- sodium
- sodium cromoglycate
- sodium ferric gluconate
- sodium iothalamate
- sotalol: postmarketing, 1% - 8%
- streptozotocin: postmarketing
- sulfacetamide
- sulfasalazine
- sulindac
- sumatriptan: rare
- sunitinib
- tacrolimus: common, 12% - 26%
- tadalafil: 5%
- tamoxifen: 1% - 4%
- tapentadol
- tazarotene
- technetium-99m
- telmisartan: postmarketing, common
- temozolomide: uncommon, common
- temsirolimus
- teniposide
- tenoxicam: uncommon
- terazosin: 0.9% - 5.5%
- testolactone
- testosterone: postmarketing
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetracaine
- thalidomide: 0% - 56.9%
- thioridazine: postmarketing
- tiagabine: frequent
- tiaprofenic acid: 1.2% - 1.9%
- tibolone
- timolol: 0.6%
- tiotropium: 3% - 5%
- tirofiban: 1%
- tizanidine: infrequent
- tolcapone: infrequent
- tolmetin
- tolterodine
- topiramate: postmarketing, 1% - 2%
- torasemide: 1.1%
- toremifene: 5%
- trabectedin
- tramazoline
- trametinib
- trandolapril
- trandolaprilat
- tranylcypromine
- travoprost
- trazodone: postmarketing, 2.8% - 7%
- treprostinil: 0.0026% - 9%
- triamcinolone
- triamcinolone acetonide
- triazolam
- trimipramine
- troglitazone: postmarketing
- tropicamide
- trospium chloride
- trovafloxacin
- v 1784: postmarketing, uncommon, common, 1% - 31.1%
- valganciclovir: 1% - 11%
- valproate
- valsartan: uncommon
- vandetanib
- varenicline: frequent
- venlafaxine: rare, frequent
- verapamil: 1.2% - 3%
- verteporfin
- vigabatrin: common
- vildagliptin
- vincristine
- vinflunine
- voriconazole
- warfarin
- zafirlukast
- zalcitabine
- zaleplon: infrequent
- zidovudine
- zidovudine/lamivudine
- zoledronic acid: postmarketing
- zolmitriptan: rare, infrequent
- zolpidem: infrequent
- zonisamide: infrequent
|
Drugs with this indication
|
